Literature DB >> 21228663

Defining phenotypes and cancer risk in hyperplastic polyposis syndrome.

Matthew F Kalady1, Awad Jarrar, Brandie Leach, Lisa LaGuardia, Margaret O'Malley, Charis Eng, James M Church.   

Abstract

BACKGROUND: Hyperplastic polyposis syndrome is a rare syndrome of colorectal cancer predisposition. Patterns of inheritance of hyperplastic polyposis syndrome are not obvious and the clinical definition is relatively arbitrary. We hypothesize that there are multiple phenotypes included in what is currently called hyperplastic polyposis syndrome. We performed this review of a large series of patients who presented with multiple serrated polyps to look for clinical patterns that may confirm our hypothesis.
METHODS: Hereditary colorectal cancer, colonoscopy, and clinical databases from a single institution were queried for patients meeting the following criteria: 1) ≥ 20 serrated colorectal polyps; 2) ≥ 5 serrated polyps proximal to the sigmoid; 3) ≥ 2 serrated polyps ≥ 10 mm in size; 4) any serrated polyps in a person with at least one first-degree relative who has hyperplastic polyposis syndrome. Records were reviewed for demographics, polyp details, and personal or family history of colorectal extracolonic malignancy.
RESULTS: One-hundred fifteen patients were included. Median age at diagnosis was 62 years and 56% were male. Ninety-seven percent were white. Twenty-five percent of patients had a personal history and 38% had a family history of colorectal cancer. Twenty-eight percent of patients had a personal history and 54% had a family history of extracolonic cancer. Phenotype analysis identified 3 patterns: relatively few large, right-sided polyps (n = 55), many small left-sided polyps (n = 18), and a combination of both left- and right-sided polyps (n = 42). The right-sided phenotype had more sessile serrated polyps and tended to develop colorectal cancer at a younger age.
CONCLUSIONS: There are at least 3 different but overlapping clinical phenotypes within hyperplastic polyposis. Recognizing this clinical heterogeneity is important in defining underlying genetic causes.

Entities:  

Mesh:

Year:  2011        PMID: 21228663     DOI: 10.1007/DCR.0b013e3181fd4c15

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  45 in total

Review 1.  Serrated Polyps of Colon and Rectum: a Clinicopathologic Review.

Authors:  Bita Geramizadeh; Scott Robertson
Journal:  J Gastrointest Cancer       Date:  2017-12

Review 2.  Familial colorectal cancer, beyond Lynch syndrome.

Authors:  Elena M Stoffel; Fay Kastrinos
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-17       Impact factor: 11.382

Review 3.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 4.  Serrated pathway: alternative route to colorectal cancer.

Authors:  Arpád V Patai; Béla Molnár; Zsolt Tulassay; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

Review 5.  Serrated Polyps and Serrated Polyposis Syndrome.

Authors:  Jean H Ashburn; Thomas P Plesec; Matthew F Kalady
Journal:  Clin Colon Rectal Surg       Date:  2016-12

6.  Sessile serrated polyps: detection, eradication, and prevention of the evil twin.

Authors:  Joshua C Obuch; Courtney M Pigott; Dennis J Ahnen
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

7.  [Gastrointestinal polyposis syndromes].

Authors:  I Spier; S Aretz
Journal:  Internist (Berl)       Date:  2012-04       Impact factor: 0.743

8.  Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis.

Authors:  Daniel L Edelstein; Marcia Cruz-Correa; Marievelisse Soto-Salgado; Jennifer E Axilbund; Linda M Hylind; Katharine Romans; Cherie Blair; Elizabeth Wiley; Anne C Tersmette; Johan A Offerhaus; Francis M Giardiello
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-11       Impact factor: 11.382

Review 9.  Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

10.  Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives.

Authors:  Yark Hazewinkel; Johannes B Reitsma; Fokko M Nagengast; Hans F Vasen; Theo A M van Os; Monique E van Leerdam; Jan-Jacob Koornstra; Evelien Dekker
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.